AN ACT CONCERNING PRESCRIPTION DRUG DISCOUNT TRANSPARENCY.

HB 6097 requires pharmacy benefit managers, pharmacies, insurers, and hospitals to report the actual cost charged to consumers for discounted prescription drugs (under Section 340B of federal law) to the Office of Health Strategy. This transparency measure aims to ensure consumers receive the full benefit of drug discounts and do not overpay or face incorrect Medicaid enrollment due to miscalculated drug costs affecting income deductions. The bill mandates these entities file specific cost reports, creating a public record of discounted drug pricing. It directly affects healthcare providers, insurers, and consumers using discounted medications, focusing on clear cost accountability.